107
Participants
Start Date
December 12, 2017
Primary Completion Date
June 13, 2019
Study Completion Date
June 27, 2019
JNJ-42847922
Participants will receive JNJ-42847922 capsule orally.
Placebo Matching to JNJ-42847922
Participants will receive placebo capsule matching to JNJ-42847922 orally.
Quetiapine XR
Participants will receive quetiapine XR capsule orally.
Placebo Matching to Quetiapine XR
Participants will receive placebo capsule matching to quetiapine XR orally.
Selective Serotonin Reuptake Inhibitor (SSRI)
Participants will receive SSRI antidepressant (such as, citalopram, escitalopram, fluvoxamine, fluoxetine, paroxetine, sertraline, vilazodone or vortioxetine) as a part of background therapy (at the same dose, without change, every day and at approximately the same time as prior to entering the study) throughout the screening, double-blind, and follow-up phases (approximately up to Week 26).
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Participants will receive SNRI antidepressant (such as duloxetine, milnacipran, levomilnacipran, venlafaxine, desvenlafaxine) as a part of background therapy (at the same dose, without change, every day and at approximately the same time as prior to entering the study) throughout the screening, double-blind, and follow-up phases (approximately up to Week 26).
Hapworth Psychiatric Medical PLLC, New York
SPRI Clinical Trials, LLC, Brooklyn
CNS Research Science, Inc., Jamaica
Johns Hopkins University School of Medicine, Baltimore
Carolina Partners c/o Tripha Life Sciences, Raleigh
Northwest Behavioral Research Center, Marietta
Premier Clinical Research, Miami
Innova Clinical Trials, Miami
Clinical Research of South Florida, Coral Gables
Arocha Research Center Inc, Miami
Stedman Clinical Trials, Tampa
Suncoast Clinical Research, New Port Richey
SIH Research, Kissimmee
Patient Priority Clinical Sites LLC, Cincinnati
American Research, LLC, Jeffersonville
Rochester Center for Behavioral Medicine (RCBM), Rochester Hills
University of Iowa, Iowa City
RxClinicals, Crystal Lake
Psychiatric Medicine Associates LLC, Skokie
Alexian Brothers Health System, Hoffman Estates
Suburban Clinical Research Group, Inc, Bolingbrook
PsychCare Consultants Research, St Louis
Midwest Research Group, Saint Charles
Phoenix Medical Research, Inc., Prairie Village
Woodland Research Northwest, Rogers
Intend Research, Norman
IPS Research Company, Oklahoma City
Sooner Clinical Research, Oklahoma City
Pillar Clinical Research, LLC, Richardson
Hawkins Psychiatry, PC, Arlington
Baylor College of Medicine, Houston
Houston Endoscopy and Research Center, Inc., Houston
Texas Center for Drug Development Inc, Houston
Ericksen Research and Development, Clinton
NoesisPharma Research, Phoenix
Clinical Research Consortium Arizona, Tempe
Pacific Institute of Medical Sciences, Los Angeles
National Research Institute, Los Angeles
Excell Research Inc, Oceanside
Artemis Institute for Clinical Research, San Diego
Desert Valley Research, Rancho Mirage
Anderson Clinical Research, Redlands
Syrentis Clinical Research, Santa Ana
Collaborative NeuroScience Network, Garden Grove
Northwest Clinical Research Center, Bellevue
Research Center for Clinical Studies, Inc., Norwalk
BTC of New Bedford, New Bedford
Boston Clinical Trials & Medical Research, Roslindale
Clinical Research Consortium, Las Vegas
BTC Network, Lincoln
Janssen Research & Development, LLC
INDUSTRY